IRIS Insights
Technical and regulatory perspectives for international manufacturers expanding in Latin America.
Regulatory Strategy
Why Ecuador is the first stop, not the last, when you're thinking about Latin America.
A $2.229 billion pharmaceutical market, a dollarized economy, high per-capita spending — attributes no other market in the region combines.
Read more →
Pharmacovigilance
The 2027 standard arrives sooner than the industry thinks. And the industry isn't ready.
ARCSA activates E-Reporting in August 2027. Most pharmacovigilance systems in operation today weren't built for that standard. We built one that is.
Read more →